![Jiayu Xu](https://profiles-cardiff.imgix.net/attachments/7990?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Ms Jiayu Xu
Teams and roles for Jiayu Xu
Research student
Publication
2026
- Chi, H. , Xu, J. and Deng, Y. 2026. AI-powered clinical decision support tools. JAMA Network Open (10.1001/jama.2026.15619)
- Chi, H. et al., 2026. Trustworthy AI for disease pathogenesis and precision medicine: A disease-agnostic framework from data to deployment. Genes & diseases 102480. (10.1016/j.gendis.2026.102480)
- Xu, H. et al., 2026. Targeting the neuro-immune axis in next-generation oncology: Discovery and validation of β2-adrenergic blockade to reverse ecosystem-wide resistance. Oncology Research : Featuring Preclinical and Clincal Cancer Therapeutics 34 (9)(10.32604/or.2026.083919)
- Zhang, L. et al., 2026. The death code in nanomessengers: Mechanisms and advances in the regulation of programmed cell death by exosomes. Life Sciences 398 124456. (10.1016/j.lfs.2026.124456)
- Chi, H. , Xu, J. and Deng, Y. 2026. BRCA1P1 immunotherapy requires pseudogene-aware transcriptomics [Letter]. Proceedings of the National Academy of Sciences 123 (29) e2616714123. (10.1073/pnas.2616714123)
- Liu, Y. et al., 2026. Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics. Apoptosis 31 128. (10.1007/s10495-026-02298-y)
Articles
- Chi, H. , Xu, J. and Deng, Y. 2026. AI-powered clinical decision support tools. JAMA Network Open (10.1001/jama.2026.15619)
- Chi, H. et al., 2026. Trustworthy AI for disease pathogenesis and precision medicine: A disease-agnostic framework from data to deployment. Genes & diseases 102480. (10.1016/j.gendis.2026.102480)
- Xu, H. et al., 2026. Targeting the neuro-immune axis in next-generation oncology: Discovery and validation of β2-adrenergic blockade to reverse ecosystem-wide resistance. Oncology Research : Featuring Preclinical and Clincal Cancer Therapeutics 34 (9)(10.32604/or.2026.083919)
- Zhang, L. et al., 2026. The death code in nanomessengers: Mechanisms and advances in the regulation of programmed cell death by exosomes. Life Sciences 398 124456. (10.1016/j.lfs.2026.124456)
- Chi, H. , Xu, J. and Deng, Y. 2026. BRCA1P1 immunotherapy requires pseudogene-aware transcriptomics [Letter]. Proceedings of the National Academy of Sciences 123 (29) e2616714123. (10.1073/pnas.2616714123)
- Liu, Y. et al., 2026. Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics. Apoptosis 31 128. (10.1007/s10495-026-02298-y)